Tag Archive | "J&J"

Janssen and Ichor Medical enter hep B vaccine delivery alliance

Tags: , , ,


Ichor Medical Systems has entered into a product development collaboration and worldwide license agreement with Janssen Pharmaceuticals Read the full story

Janssen acquires XO1 for ichorcumab

Tags: , , ,


Janssen Pharmaceuticals has acquired XO1 Limited Read the full story

Cardinal Health agrees to acquire Cordis from J&J

Tags: , ,


Big pharma giant Johnson & Johnson has found a buyer for its Cordis unit, a manufacturer of cardiology and endovascular devices, which it put on the market in August 2014 . Read the full story

Genzyme and Voyager in $845 million AAV gene therapy pact

Tags: , , ,


Voyager Therapeutics and Genzyme announced a major strategic collaboration to discover, develop and commercialize novel gene therapies for severe CNS disorders Read the full story

Depomed gains rights to Nucynta from J&J

Tags: , ,


Depomed has entered into a definitive agreement to acquire the U.S. rights to the NUCYNTA franchise from Janssen Pharmaceuticals for $1.05 billion Read the full story

Vedanta and Janssen partner for VE202

Tags: , , ,


Vedanta Biosciences announced a license agreement with Janssen Biotech, for Vedanta's lead microbiome pharmaceutical candidate (VE202) Read the full story

Janssen and AC Immune partner for ACI-35

Tags: , , , ,


AC Immune has entered into a worldwide exclusive license agreement and research collaboration with Janssen Pharmaceuticals Read the full story

Janssen and Vectura partner for anti-inflammatory therapies for asthma/COPD

Tags: , , , ,


Vectura has entered into a global development and licence agreement with Janssen Biotech for the exclusive development of novel anti-inflammatory therapies for the treatment of asthma/COPD Read the full story

Janssen and Isis in RNA-targeted therapeutics pact

Tags: , , ,


Isis Pharmaceuticals has entered into a global collaboration with Janssen Biotech to discover and develop antisense drugs to treat autoimmune disorders of the gastrointestinal (GI) tract Read the full story

Janssen licenses Tipifarnib to EB Pharma

Tags: , , ,


EB Pharma has executed an agreement with Janssen Pharmaceutica for an exclusive license, to tipifarnib in the field of virology and a related, clinical stage back-up compound Read the full story